The scientific work required to stop COVID-19 may seem mysterious to many, so Scripps Research has released an informative new COVID-19 video collection as a public service, taking viewers directly into scientists’ laboratories and providing a glimpse into their thought process as they work to find the vulnerabilities of the pandemic virus sweeping the globe. In this series of short videos geared toward the general public, Scripps Research scientists discuss their strategies for developing selective, safe treatments and vaccines against the novel Coronavirus on an unprecedented timescale.
“More than 100 Scripps Research scientists are working to decipher the dangerous new coronavirus responsible for outbreaks of respiratory illness across the globe,” says Douglas Bingham, executive Vice President of Florida Operations at Scripps Research Institute. “On both U.S. coasts, teams of chemists and biologists are focused on developing antiviral therapies and vaccine prototypes which are optimized for both safety and effectiveness. Our new video series sheds light on how Scripps Research scientists are tackling this difficult task – and offers an educational look at the essential, urgent scientific work underway to protect the public from this pandemic.”
For detailed, regularly updated reports on the many ways Scripps Research scientists are addressing the pandemic, visit https://www.scripps.edu/covid-19/ .
All videos in the collection can be found via the Scripps Research YouTube channel. Those filmed from our Jupiter, Florida campus are at the hyperlinks below:
How scientists are confronting coronavirus: Scripps Research COVID-19 updates
Around the world, scientists are sharing data, sharing insights, pushing for the best possible vaccines and medications against COVID-19. Virologist Michael Farzan, PhD, describes the scale of the effort underway at Scripps Research.
How does the coronavirus sicken people? A virologist explains
The pandemic strain of coronavirus infects cells in the lung, leading to an aggressive immune response that can be life-threatening. Virologist Hyeryun Choe, PhD, at Scripps Research, Florida answers common questions about COVID-19.
Using robotics to rapidly screen for COVID-19 medicines
The merger of outstanding basic scientific research, industrial robotics and a unique drug-discovery collection powers the battle against COVID-19 at the Scripps Research, Florida campus. Louis Scampavia, PhD, and Timothy Spicer, PhD, describe the high-throughput drug screening program at Scripps Research in Jupiter, Florida.
Probing coronavirus genetics for new points of attack
One scientist’s inventive tools for repairing toxic RNA now reveal ways to fight pandemic coronaviruses, which store their genetic information in RNA. Scripps Research, Florida chemist Matthew Disney, PhD, takes you inside his lab’s fight against COVID-19.
Antibodies, biologics and the fight against COVID-19
Besides vaccines and antiviral drugs, a group of medicines called biologics offer great potential in the battle against COVID-19. Serum from recovered patients can be used to protect others and also to identify useful antibodies, our immune system’s precision germ-targeting system. In Jupiter, Florida, Scripps Research molecular biologist Christoph Rader, PhD, explains.
News organizations are welcome to use the videos all or in part for news segments that feature Scripps Research COVID-19 expertise and research, with attribution.
Exclusive interviews with featured scientists are also available on request via telephone, Zoom, Skype or other video service.
About Scripps Research
Scripps Research is an independent, nonprofit biomedical institute ranked the most influential in the world for its impact on innovation. With campuses in La Jolla, California, and Jupiter, Florida, we are advancing human health through profound discoveries that address pressing medical concerns around the globe. Our drug discovery and development division, Calibr, works hand-in-hand with scientists across disciplines to bring new medicines to patients as quickly and efficiently as possible, while teams at Scripps Research Translational Institute harness genomics, digital medicine and cutting-edge informatics to understand individual health and render more effective healthcare. Scripps Research also trains the next generation of leading scientists at our Skaggs Graduate School, consistently named among the top 10 U.S. programs for chemistry and biological sciences. Learn more at www.scripps.edu.